Hello,
Obat termasuk dlm obat yg cukup berbahaya:
Langkah yg luar biasa utk ingin menghabiskan nyawa seseorg (janin)yg
merup[kan karunia Tuhan dg produk ini.
Hendaknya mengetahui bahwa produk ini adalah:
PATIENTS MUST BE ADVISED OF THE ABORTIFACIENT PROPERTY AND WARNED NOT TO
GIVE THE DRUG TO OTHERS.
Cytotec should not be used for reducing the risk of NSAID-induced ulcers
in women of childbearing potential unless the patient is at high risk of
complications from gastric ulcers associated with use of the NSAID, or
is at high risk of developing gastric ulceration. In such patients,
Cytotec may be prescribed *if *the patient
* has had a negative serum pregnancy test within 2 weeks prior to
beginning therapy.
* is capable of complying with effective contraceptive measures.
* has received both oral and written warnings of the hazards of
misoprostol, the risk of possible contraception failure, and the
danger to other women of childbearing potential should the drug be
taken by mistake.
* will begin Cytotec only on the second or third day of the next
normal menstrual period.
Silahkan anda baca selanjutnya sendiri.
Sallam dalam kasih,
Drug Description
*Cytotec® *(misoprostol) Tablets
*WARNINGS*
*CYTOTEC (MISOPROSTOL) ADMINISTRATION TO WOMEN WHO ARE PREGNANT CAN
CAUSE ABORTION,
PREMATURE BIRTH,
OR BIRTH DEFECTS.
*
* UTERINE RUPTURE
*
*HAS BEEN REPORTED WHEN CYTOTEC WAS ADMINISTERED IN PREGNANT WOMEN TO
INDUCE LABOR OR TO INDUCE ABORTION BEYOND THE EIGHTH WEEK OF PREGNANCY
(see also PRECAUTIONS and LABOR AND DELIVERY). CYTOTEC SHOULD NOT BE
TAKEN BY PREGNANT WOMEN TO REDUCE THE RISK OF ULCERS INDUCED BY
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) (see CONTRAINDICATIONS,
WARNINGS, and PRECAUTIONS).*
PATIENTS MUST BE ADVISED OF THE ABORTIFACIENT PROPERTY AND WARNED NOT TO
GIVE THE DRUG TO OTHERS.
Cytotec should not be used for reducing the risk of NSAID-induced ulcers
in women of childbearing potential unless the patient is at high risk of
complications from gastric ulcers associated with use of the NSAID, or
is at high risk of developing gastric ulceration. In such patients,
Cytotec may be prescribed if the patient
* has had a negative serum pregnancy test within 2 weeks prior to
beginning therapy.
* is capable of complying with effective contraceptive measures.
* has received both oral and written warnings of the hazards of
misoprostol, the risk of possible contraception failure, and the
danger to other women of childbearing potential should the drug be
taken by mistake.
* will begin Cytotec only on the second or third day of the next
normal menstrual period.
DRUG DESCRIPTION
Cytotec oral tablets contain either 100 mcg or 200 mcg of misoprostol, a
synthetic prostaglandin E_1 analog.
Misoprostol contains approximately equal amounts of the two
diastereomers presented below with their enantiomers indicated by (±):
Cytotec (misoprostol) structural formula illustration
Misoprostol is a water-soluble, viscous liquid.
Inactive ingredients of tablets are hydrogenated castor oil,
hypromellose, microcrystalline cellulose, and sodium starch glycolate.
INDICATIONS
Cytotec (misoprostol) is indicated for reducing the risk of NSAID
(nonsteroidal anti- inflammatory drugs, including aspirin)-induced
gastric ulcers in patients at high risk of complications from gastric
ulcer, e.g., the elderly and patients with concomitant debilitating
disease, as well as patients at high risk of developing gastric
ulceration, such as patients with a history of ulcer. Cytotec has not
been shown to reduce the risk of duodenal ulcers in patients taking
NSAIDs. Cytotec should be taken for the duration of NSAID therapy.
Cytotec has been shown to reduce the risk of gastric ulcers in
controlled studies of 3 months' duration. It had no effect, compared to
placebo, on gastrointestinal pain or discomfort associated with NSAID use.
DOSAGE AND ADMINISTRATION
The recommended adult oral dose of Cytotec for reducing the risk of
NSAID-induced gastric ulcers is 200 mcg four times daily with food. If
this dose cannot be tolerated, a dose of 100 mcg can be used. (See
*CLINICAL PHARMACOLOGY*: *Clinical studies*.) Cytotec should be taken
for the duration of NSAID therapy as prescribed by the physician.
Cytotec should be taken with a meal, and the last dose of the day should
be at bedtime.
*Renal impairment*: Adjustment of the dosing schedule in renally
impaired patients is not routinely needed, but dosage can be reduced if
the 200-mcg dose is not tolerated. (See *CLINICAL PHARMACOLOGY*.)
HOW SUPPLIED
Cytotec 100-mcg tablets are white, round, with SEARLE debossed on one
side and 1451 on the other side; supplied as:
*NDC Number Size*
0025-1451-60unit-of-use bottle of 60
0025-1451-20unit-of-use bottle of 120
0025-1451-34carton of 100 unit dose
